Published in Liver Transpl on March 01, 2010
Hepatocellular carcinoma: clinical frontiers and perspectives. Gut (2014) 5.79
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl (2013) 2.53
HCC patients suffer less from geographic differences in organ availability. Am J Transplant (2013) 1.52
Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology (2014) 1.52
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14
Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2011) 1.07
HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology (2014) 1.00
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again. Int J Hepatol (2012) 0.96
Management of hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.96
Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology (2015) 0.92
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol (2013) 0.92
Hepatocellular Carcinoma and Liver Transplantation: State of the Art. J Clin Transl Hepatol (2014) 0.90
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol (2015) 0.88
Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? J Am Coll Surg (2013) 0.87
Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol (2013) 0.83
How grim is hepatocellular carcinoma? Ann Med Surg (Lond) (2014) 0.83
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. Hepatology (2016) 0.82
Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol (2014) 0.82
Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2013) 0.82
The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci (2013) 0.81
Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand? World J Gastroenterol (2014) 0.81
Intermediate hepatocellular carcinoma: How to choose the best treatment modality? World J Hepatol (2015) 0.80
Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm. Clin Mol Hepatol (2016) 0.80
Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79
Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? HPB (Oxford) (2012) 0.79
Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol (2014) 0.78
Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol (2016) 0.78
The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases. BMC Med Imaging (2014) 0.78
Current status of multimodal & combination therapy for hepatocellular carcinoma. Indian J Med Res (2012) 0.78
Current Treatment Approaches to HCC with a Special Consideration to Transplantation. J Transplant (2016) 0.78
Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant (2015) 0.78
Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl (2015) 0.78
Female gender in the setting of liver transplantation. World J Transplant (2014) 0.77
Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon (2011) 0.77
Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review. Int Surg (2014) 0.77
Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making. Br J Cancer (2016) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation (2017) 0.76
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol (2016) 0.76
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol (2016) 0.75
De novo Hepatocellular Carcinoma after Liver Transplantation. J Clin Transl Hepatol (2015) 0.75
MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol (2015) 0.75
Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma. PLoS One (2017) 0.75
Liver allocation for patients with hepatocellular carcinoma. Liver Transpl (2010) 0.75
Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes. Hepatobiliary Surg Nutr (2016) 0.75
HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations? Visc Med (2016) 0.75
The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clin Transl Imaging (2016) 0.75
Model for end-stage liver disease exceptions: proceed with caution. Liver Transpl (2011) 0.75
Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLoS One (2016) 0.75
Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same? Transl Gastroenterol Hepatol (2017) 0.75
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology (2005) 3.51
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
Metal-organic framework materials as catalysts. Chem Soc Rev (2009) 2.96
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer (2009) 2.78
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl (2014) 2.71
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol (2010) 2.51
Principles of and advances in percutaneous ablation. Radiology (2011) 2.44
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology (2005) 2.38
Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transpl (2009) 2.35
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Liver allocation and distribution: possible next steps. Liver Transpl (2011) 2.14
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14
Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology (2009) 2.12
Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography. Urology (2005) 2.08
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail (2011) 1.99
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2005) 1.89
Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom (2008) 1.88
Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88
Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol (2003) 1.85
Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol (2010) 1.84
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Hospital accused of experiments on pregnant women. BMJ (1994) 1.73
Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70
US researchers fail to get informed consent. BMJ (1994) 1.61
Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl (2004) 1.59
Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res (2009) 1.58
Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type. Transplantation (2008) 1.58
Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation (2004) 1.57
Hypophosphatemia after 95 right-lobe living-donor hepatectomies for liver transplantation is not a significant source of morbidity. Transplantation (2003) 1.57
Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl (2002) 1.57
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl (2006) 1.56
Three-Dimensional finite-element analyses for radio-frequency hepatic tumor ablation. IEEE Trans Biomed Eng (2002) 1.55
Use of carotid-subclavian arterial bypass and thoracic endovascular aortic repair to minimize cerebral ischemia in total aortic arch reconstruction. J Thorac Cardiovasc Surg (2010) 1.54
Ionizing radiation in abdominal CT: unindicated multiphase scans are an important source of medically unnecessary exposure. J Am Coll Radiol (2011) 1.52
Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation. Ann Thorac Surg (2011) 1.52
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Microwave ablation with multiple simultaneously powered small-gauge triaxial antennas: results from an in vivo swine liver model. Radiology (2007) 1.50
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49
Sonographic diagnosis of superior hemispheric testicular infarction. AJR Am J Roentgenol (2002) 1.47
Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol (2003) 1.47
Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46
Fetal lung-head ratio is not related to outcome for antenatal diagnosed congenital diaphragmatic hernia. J Pediatr Surg (2007) 1.45
The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I. Eur J Nucl Med Mol Imaging (2002) 1.45
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology (2005) 1.44
Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl (2004) 1.44
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
Noncomposite simultaneous liver and intestinal transplantation. Transplantation (2003) 1.43
A three-dimensional echocardiographic study on aortic-mitral coupling in transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging (2013) 1.43
Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant (2007) 1.43
Microwave Ablation With a Triaxial Antenna: Results in ex vivo Bovine Liver. IEEE Trans Microw Theory Tech (2005) 1.42
Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transpl (2006) 1.41
Organ donation after cardiac death in amyotrophic lateral sclerosis. Ann Neurol (2012) 1.41
Characteristics of diabetes after pediatric liver transplant. Pediatr Transplant (2012) 1.39
Richard Freeman on yoga as a path to physical and spiritual health. Interview by Bonnie Horrigan. Altern Ther Health Med (2004) 1.39
Elastographic measurement of the area and volume of thermal lesions resulting from radiofrequency ablation: pathologic correlation. AJR Am J Roentgenol (2003) 1.39
Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology (2004) 1.39
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology (2009) 1.35
Hepatic radiofrequency ablation with internally cooled probes: effect of coolant temperature on lesion size. IEEE Trans Biomed Eng (2003) 1.34
Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol (2004) 1.33
Anatomic variations in right liver living donors. J Am Coll Surg (2004) 1.33
Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab Invest (2008) 1.32
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol (2008) 1.29
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation (2010) 1.28
Microcomputed tomography colonography for polyp detection in an in vivo mouse tumor model. Proc Natl Acad Sci U S A (2005) 1.27
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl (2010) 1.26
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26
Cryoablation for liver cancer. Tech Vasc Interv Radiol (2007) 1.24
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol (2013) 1.24
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology (2008) 1.24
Three-dimensional electrode displacement elastography using the Siemens C7F2 fourSight four-dimensional ultrasound transducer. Ultrasound Med Biol (2008) 1.23
Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol (2010) 1.23
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res (2005) 1.23